HM hospitales spain radiation therapy elekta versa hd mosaiq

October 30, 2013 — HM Hospitales, a private hospital group in Spain, anticipates treating its first patients with Elekta's Versa HD system in 2015. 
 
Versa HD, to be sited in the group's sixth hospital, is a radiation treatment system designed to enhance the management of cancer care and treat a broad spectrum of tumors throughout the body. It is a single-system linear accelerator capable of delivering conventional therapies for an expansive range of indications commonly seen in the clinic while also permitting treatment of complex cancers that require exceptional targeting accuracy.
 
"Versa HD will allow us to treat patients with the most modern radiation therapy techniques, from traditional treatments to radiosurgery procedures," said Juan Abarca Cidon, M.D., general manager, HM Hospitales. "We will use Versa HD for virtually all cancer pathologies located throughout the body. The system's High Dose Rate mode and ultra-fast and precise Agility beam shaping capabilities also will improve the speed with which we can deliver therapy, which will improve patient comfort through shorter treatment times."
 
The new medical center, Hospital HM Universitario Puerto del Sur, will be connected to the hospital group's first radiation oncology department — Clara Campal Comprehensive Cancer Center, HM Sanchinarro — via Elekta's Mosaiq Oncology Information System (OIS). It will replace the Siemens Lantis OIS that had been in use at the cancer center.
 
"The Puerto del Sur clinic will serve an area of approximately one million inhabitants in the area south of Madrid," said Cidon. "It is important that we provide cancer patients in Mostoles and the wider region with access to the very latest treatment technology."
 
For more information: www.versahd.com, www.elekta.com
 

Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now